Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Shortages (3)
- Therapeutic goods regulation (38)
- Manufacturing (26)
- Regulatory compliance (26)
- Unique Device Identification (UDI) hub (20)
- In Vitro Diagnostic medical devices (IVDs) (19)
- Prescription medicines (17)
- Safety (10)
- Clinical trials (9)
- Medical devices safety (9)
- Australian Register of Therapeutic Goods (ARTG) (8)
- Legislation (8)
- Medicine safety (8)
- Vaping hub (8)
- Scheduling (national classification system) (7)
- Medicinal cannabis hub (5)
- Over the counter (OTC) medicines (5)
- Advertising (4)
- Listed medicines (4)
- Non-prescription medicines (3)
- Breast implant hub (2)
- Complementary medicines (2)
- Compliance and enforcement hub (2)
- Pharmacovigilance (2)
- Advanced therapies (1)
- Advisory bodies and committees (1)
- Alert/Advisory (1)
- Cosmetics (1)
- COVID-19 vaccines (1)
- Import and export (1)
- Labelling and packaging (1)
- TGA conformity assessment certification (1)
Search
3 result(s) found, displaying 1 to 3
-
PresentationsSee the upcoming changes in the PRAC – the new procedure document that will replace the Uniform Recalls Procedure for Therapeutic Goods (URPTG).
-
WebinarsThis webinar provides information on the TGA’s public consultation on the impacts, challenges and opportunities relating to medicine shortages.
-
PresentationsA presentation discussing the lessons learnt from the Actemra (tocilizumab) shortage.